DE69327693T2 - Interferon-Alpha/Beta bindendes Protein, seine Herstellung und seine enthaltende pharmazeutische Zusammensetzungen - Google Patents

Interferon-Alpha/Beta bindendes Protein, seine Herstellung und seine enthaltende pharmazeutische Zusammensetzungen

Info

Publication number
DE69327693T2
DE69327693T2 DE69327693T DE69327693T DE69327693T2 DE 69327693 T2 DE69327693 T2 DE 69327693T2 DE 69327693 T DE69327693 T DE 69327693T DE 69327693 T DE69327693 T DE 69327693T DE 69327693 T2 DE69327693 T2 DE 69327693T2
Authority
DE
Germany
Prior art keywords
interferon
alpha
pharmaceutical compositions
binding protein
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69327693T
Other languages
English (en)
Other versions
DE69327693D1 (de
Inventor
Daniela Novick
Menachem Rubinstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
Original Assignee
Yeda Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL103052A external-priority patent/IL103052A/en
Application filed by Yeda Research and Development Co Ltd filed Critical Yeda Research and Development Co Ltd
Application granted granted Critical
Publication of DE69327693D1 publication Critical patent/DE69327693D1/de
Publication of DE69327693T2 publication Critical patent/DE69327693T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
DE69327693T 1992-09-03 1993-09-02 Interferon-Alpha/Beta bindendes Protein, seine Herstellung und seine enthaltende pharmazeutische Zusammensetzungen Expired - Lifetime DE69327693T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL103052A IL103052A (en) 1992-09-03 1992-09-03 Soluble interferon-alpha receptors,their preparation and pharmaceutical compositions containing them
IL106591A IL106591A (en) 1992-09-03 1993-08-04 Interferon alpha/beta binding protein, its preparation and pharmaceutical compositions containing it

Publications (2)

Publication Number Publication Date
DE69327693D1 DE69327693D1 (de) 2000-03-02
DE69327693T2 true DE69327693T2 (de) 2000-09-07

Family

ID=26322502

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69327693T Expired - Lifetime DE69327693T2 (de) 1992-09-03 1993-09-02 Interferon-Alpha/Beta bindendes Protein, seine Herstellung und seine enthaltende pharmazeutische Zusammensetzungen

Country Status (11)

Country Link
EP (1) EP0588177B1 (de)
JP (3) JP3662264B2 (de)
AT (1) ATE189262T1 (de)
AU (1) AU674523B2 (de)
CA (1) CA2105449C (de)
DE (1) DE69327693T2 (de)
DK (1) DK0588177T3 (de)
ES (1) ES2142840T3 (de)
GR (1) GR3032891T3 (de)
IL (1) IL106591A (de)
PT (1) PT588177E (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL108584A (en) * 1994-02-07 2008-03-20 Yeda Res & Dev Cloning of the interferon-binding protein ALPHA / BETA
US5821078A (en) * 1992-09-03 1998-10-13 Yeda Research And Development Co. Ltd. Nucleic acid encoding interferon-α/β binding protein
IL107378A (en) * 1993-10-24 2005-05-17 Yeda Res & Dev SOLUBLE INTERFERON alpha-RECEPTOR, ITS PREPARATION AND USE
IL118096A0 (en) * 1996-05-01 1996-09-12 Yeda Res & Dev Antibodies against interferon alpha/beta receptor
AU4070897A (en) * 1996-08-16 1998-03-06 Kurt B. Osther Method for treating diabetes
ATE285076T1 (de) * 1996-08-19 2005-01-15 Shaker Ghassan I Verwendung von molt4 cd69 expression zur bestimmung der anwesenheit und der aktivität von interferoninhibitoren
EA003635B1 (ru) 1997-12-19 2003-08-28 Апплайд Резеч Системз Арс Холдинг Н.В. Комплекс ifnar2/ifn
US20070081995A1 (en) * 2005-06-22 2007-04-12 Genentech, Inc. Methods and compositions for targeting IFNAR2

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL88377A (en) * 1988-11-14 1996-09-12 Yeda Res & Dev Cloning and expression of a protein which modulates cellular response to type I interferon
FR2657881A1 (fr) * 1990-02-05 1991-08-09 Europ Biotechnologie Lab Nouveaux polypeptides hydrosolubles, sequences d'adn, nouvelles cellules, procede de preparation, applications et compositions renfermant lesdits polypeptides.

Also Published As

Publication number Publication date
CA2105449C (en) 2010-07-20
EP0588177A3 (en) 1994-08-17
DK0588177T3 (da) 2000-05-08
IL106591A0 (en) 1993-12-08
EP0588177B1 (de) 2000-01-26
AU4609693A (en) 1994-03-10
JPH06220100A (ja) 1994-08-09
JP2004254695A (ja) 2004-09-16
CA2105449A1 (en) 1994-03-04
JP2005162762A (ja) 2005-06-23
JP3907661B2 (ja) 2007-04-18
AU674523B2 (en) 1997-01-02
ATE189262T1 (de) 2000-02-15
PT588177E (pt) 2000-05-31
JP3662264B2 (ja) 2005-06-22
DE69327693D1 (de) 2000-03-02
GR3032891T3 (en) 2000-07-31
IL106591A (en) 2008-03-20
ES2142840T3 (es) 2000-05-01
EP0588177A2 (de) 1994-03-23

Similar Documents

Publication Publication Date Title
DE3881443D1 (de) Imidazol-verbindung und diese enthaltende biozide zusammensetzungen.
DE69021387D1 (de) Medizinische aerosolformulierungen.
FI901102A0 (fi) Farmaceutiska kompositioner.
FI922364A0 (fi) Farmaceutiska kompositioner.
IL85609A0 (en) Phenyl carbamate,its preparation and pharmaceutical compositions containing it
DE3769458D1 (de) Physiologisch wirksame und naehrende zusammensetzung.
IT8920486A0 (it) Composizioni farmaceutiche.
DE69011813T2 (de) Kaugummizusammensetzung und ihre Herstellung.
DE69012702D1 (de) Dentalzusammensetzung.
DE3867659D1 (de) 1,5-diphenyl-1h-1,2,4-triazol-3-carboxamid-derivate und diese enthaltende herbizide zusammensetzungen.
IT8820386A0 (it) Composizioni farmaceutiche orosolubili contenti acetilcisteina.
IT9019754A0 (it) Composizioni farmaceutiche,dietetiche o veterinarie ad attivita' eumetabolica
FI883673A0 (fi) Farmaceutiska kompositioner.
DE69012650T2 (de) Piperidinderivat, Verfahren zur Herstellung davon und dieses enthaltende pharmazeutische Zusammensetzung.
DE3887068D1 (de) 2,2-Dimethylchromenderivate, Verfahren zur Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
DE69327693T2 (de) Interferon-Alpha/Beta bindendes Protein, seine Herstellung und seine enthaltende pharmazeutische Zusammensetzungen
IT8820388A0 (it) Composizione oftalmologica.
DE3576505D1 (de) 3,4-dihydrobenzopyranverbindungen und diese enthaltende pharmazeutische zusammenstellungen.
DE69009795D1 (de) Muramylpeptid-Derivate und diese enthaltende immunregulierende Zusammensetzungen.
DE68905973D1 (de) Synergistische suessungsmittel-zusammensetzungen, enthaltend chlorodeoxysucrase, und diese enthaltende zusammensetzungen.
DE3864865D1 (de) Duftzusammensetzung.
IT1233411B (it) Composizione insetticida.
DE3761561D1 (de) N,n-bis-(4-fluorophenyl)carbamoylacetohydroxamsaeure und diese enthaltende pharmazeutische zusammensetzungen.
DE3871159D1 (de) Pharmazeutische und tieraerztliche zusammensetzungen.
DE3688451D1 (de) Konjugate von vinblastin und seine derivate, verfahren zur herstellung derselben und diese konjugate enthaltende pharmazeutische zusammensetzungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition